Challenges in the measurement of serum testosterone concentrations as a biomarker of men's health;Methodische Aspekte zur Bestimmung der Testosteronkonzentration als Biomarker der Gesundheit des Mannes

LaboratoriumsMedizin

Volumn 35, Issue 1, 2011, Pages 29-33

  Haring, Robin ^a   Spielhagen, Christin ^a   Nauck, Matthias ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

androgens; biomarker; immunoassay; mass spectrometry; testosterone

Indexed keywords

BIOLOGICAL MARKER; TESTOSTERONE;

ARTICLE; HEALTH; HUMAN; MALE; MEASUREMENT; TESTOSTERONE BLOOD LEVEL;

EID: 79953897752     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2011.001     Document Type: Article

References (52)

1. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123-35.
2. Friedrich N, Rosskopf D, Brabant G, Völzke H, Nauck M, Wal-laschofski H. Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes 2010;118:266-73.
3. Haring R, Baumeister SE, Völzke H, Dörr M, Felix SB, Kroe-mer HK, et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil 2010, Jun 17. Epub ahead of print.
4. Völzke H, Aumann N, Krebs A, Nauck M, Steveling A, Lerch MM, et al. Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J androl 2010;33:45-53.
5. Haring R, Völzke H, Felix SB, Schipf S, Dörr M, Rosskopf D, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Po-merania. Diabetes 2009;58:2027-31.
6. Schipf S, Haring R, Friedrich N, Nauck M, Lau K, Alte D, et al. Low total testosterone is associated with increased risk of incident Type 2 diabetes mellitus in men: Results from the Study of Health in Pomerania (SHIP). Aging Male 2010; Nov 2. Epub ahead of print.
7. Torkler S, Wallaschofski H, Baumeister SE, Völzke H, Dörr M, Felix SB, et al. Inverse Association Between Total Testosterone Concentrations, Incident Hypertension, and Blood Pressure. Aging Male 2010; Nov 19. Epub ahead of print.
8. Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009;21:261-4.
9. Haring R, Völzke H, Steveling A, Krebs A, Felix SB, Schoefl C, et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 2010;31:1494-501.
10. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005;26:833-76. (Pubitemid 41428540)
11. Svartberg J, Jorde R, Sundsfjord J, Bonaa KH, Barrett-Connor E. Seasonal variation of testosterone and waist to hip ratio in men: the Tromso study. J Clin Endocrinol Metab 2003;88:3099-104. (Pubitemid 36877478)
12. Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003;58:710-7. (Pubitemid 36702730)
13. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J clin Endo-crinol Metab 2009;94:907-13.
14. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-59.
15. Cameron JL, Helmreich DL, Schreihofer DA. Modulation of reproductive hormone secretion by nutritional intake: stress signals versus metabolic signals. Hum Reprod 1993;8:162-7. (Pubitemid 23337198)
16. Jeibmann A, Zahedi S, Simoni M, Nieschlag E, Byrne MM. Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males. Eur J clin invest 2005;35:565-72. (Pubitemid 41243300)
17. Halford C, Anderzen I, Arnetz B. Endocrine measures of stress and self-rated health: a longitudinal study. J Psychosom Res 2003;55:317-20. (Pubitemid 38367755)
18. Haring R, Ittermann T, Völzke H, Krebs A, Zygmunt M, Felix SB, et al. Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 2010;13:247-57.
19. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKin-lay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J clin endocrinol metab 2007;92:549-55.
20. Carruthers M, Trinick TR, Wheeler MJ. The validity of andro-gen assays. Aging Male 2007;10:165-72.
21. Friedrich N, Völzke H, Rosskopf D, Steveling A, Krebs A, Nauck M, et al. Reference ranges for serum dehydroepian-drosterone sulfate and testosterone in adult men. J Androl 2008;29:610-7.
22. Valero-Politi J, Fuentes-Arderiu X. Within- and between-subject biological variations of follitropin, lutropin, testosterone, and sex-hormone-binding globulin in men. Clin Chem 1993;39:1723-5. (Pubitemid 23246009)
23. Wheeler MJ, Barnes SC. Measurement of testosterone in the diagnosis of hypogonadism in the ageing male. Clin Endocrinol (Oxf) 2008;69:515-25.
24. Hammer EJ, Astley JP. Increase in serum testosterone following contact with blood cells. Ann clin biochem 1985;22:539-40. (Pubitemid 16241859)
25. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, et al. Validity for epidemiological studies of long-term cryo-conservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 1995;4:509-13.
26. Stroud LR, Solomon C, Shenassa E, Papandonatos G, Niaura R, Lipsitt LP, et al. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. Psychoneuroendocrinology 2007;32:140-50.
27. Bauman JE. Stability of radioimmunoassayable steroid and protein hormones after repeated freeze-thaw cycles. Clin Chem 1982;28:2336-7.
28. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Utility, Limitations, and Pitfalls in Measuring Testosterone: An Endocrine Society Position Statement. J Clin Endocrinol Metab 2007;92: 405-13.
29. Schönicke G, Junge M. Der Testosteronspiegel - Messung und analytische Bewertung. Blickpunkt der Mann 2006;4:19-22.
30. Hsing AW, Stanczyk FZ, Belanger A, Schroeder P, Chang L, Falk RT, et al. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomar-kers Prev 2007;16:1004-8. (Pubitemid 46910104)
31. Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin Chem 2009;55:1061-6.
32. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatogra-phy-tandem mass spectrometry. J Clin Endocrinol Metab 2004;89:534-43. (Pubitemid 38269854)
33. Stanczyk FZ, Lee JS, Santen RJ. Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol Biomar-kers Prev 2007;16:1713-9. (Pubitemid 47450498)
34. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH, et al. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151-8. (Pubitemid 34150134)
35. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49:1381-95. (Pubitemid 36900626)
36. Matsumoto AM, Bremner WJ. Serum testosterone assays-accuracy matters. J Clin Endocrinol Metab 2004;89:520-4.
37. Vesper HW, Bhasin S, Wang C, Tai SS, Dodge LA, Singh RJ, et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 2009;74:498-503.
38. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 2009;30:1-9.
39. Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC, et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 2008;54:1290-7.
40. Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol 2010;121:491-5.
41. Vesper HW, Botelho JC. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol 2010;121: 513-9.
42. De Ronde W, van der Schouw YT, Pols HA, Gooren LJ, Muller M, Grobbee DE, et al. Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin Chem 2006;52:1777-84. (Pubitemid 44330714)
43. Rosner W. Errors in the measurement of plasma free testosterone. J Clin Endocrinol Metab 1997;82:2014-5.
44. Swerdloff RS, Wang C. Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence. Clin Chem 2008;54:458-60. (Pubitemid 351348150)
45. Mazer NA. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estra-diol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 2009;74:512-9.
46. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672 (Pubitemid 30645223)
47. Ceglarek U, Werner M, Kortz L, Korner A, Kiess W, Thiery J, et al. Preclinical challenges in steroid analysis of human samples. J Steroid Biochem Mol Biol 2010;121:505-12.
48. Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl 2003;24:299-311. (Pubitemid 39571784)
49. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363:109-22.
50. Nieschlag E, Wang C, Swerdloff R, Behre H, Helstrom WJ, Gooren LJ, et al. Untersuchung, Behandlung und Überwachung des Altershypogonadismus (Late-onset hypogonadism) des Mannes: ISA-, ISSAM-, EAU-, EAA- und ASA-Empfehlungen. J Reproduktionsmed Endokrinol 2010;7:60-6.
51. McLachlan RI. Certainly more guidelines than rules. J clin En-docrinol Metab 2010;95:2610-3.
52. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005;63:280-93. (Pubitemid 41233445)